Better Handling of Electronic Communications During Government Investigations and Discovery: What Health Care Companies Can Learn from Other Industries
July 1, 2022
In today’s increasingly complex and ever-changing health care business climate, companies embroiled in government investigations or litigation often find themselves struggling to comply with Department of Justice civil investigative demands (CIDs), subpoenas, or document requests. Even under the best of circumstances, document collection, processing, and review are time consuming and expensive. Moreover, CIDs and document requests in false claims and other government investigations are often very broad and have unrealistic deadlines.
Read the full article by clicking here.
This article was published by the American Health Law Association and is reprinted here by permission.
Author(s)
Related Insights
June 3, 2025
Foley Corporate Governance Update
Texas Senate Bill 2337: Protecting Texas Companies and Their Directors, Shareholders and Boards from Proxy Advice Not in the Financial Interests of Shareholders
On June 2, 2025, the Texas Legislature passed Senate Bill 2337, meaningfully regulating proxy advisors like ISS and Glass Lewis when providing proxy voting recommendations concerning Texas companies.
September 25, 2025
Events
Unclaimed Property Roundtable with Delaware State Escheator and Leading Practitioners
June 3, 2025
Health Care Law Today
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.